Long-term real-world outcomes of nusinersen treatment in patients with spinal muscular atrophy types I-III.

Aliyeva G, Mergen Kılıç S, Yapıcı Z, Topaloğlu P

Open source

DOI
10.1016/j.braindev.2026.104601
Published
2026 Oct 5
Container
Brain & development
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.braindev.2026.104601,
  title = {Long-term real-world outcomes of nusinersen treatment in patients with spinal muscular atrophy types I-III.},
  author = {Aliyeva G and Mergen Kılıç S and Yapıcı Z and Topaloğlu P},
  year = {2026},
  journal = {Brain \& development},
  doi = {10.1016/j.braindev.2026.104601},
  url = {https://doi.org/10.1016/j.braindev.2026.104601}
}

RIS

TY  - JOUR
TI  - Long-term real-world outcomes of nusinersen treatment in patients with spinal muscular atrophy types I-III.
AU  - Aliyeva G
AU  - Mergen Kılıç S
AU  - Yapıcı Z
AU  - Topaloğlu P
PY  - 2026
JO  - Brain & development
DO  - 10.1016/j.braindev.2026.104601
UR  - https://doi.org/10.1016/j.braindev.2026.104601
ER  - 

APA

G, A., S, M. K., Z, Y., & P, T. (2026). Long-term real-world outcomes of nusinersen treatment in patients with spinal muscular atrophy types I-III.. Brain & development. https://doi.org/10.1016/j.braindev.2026.104601

Source records